Femasys, Inc. (FEMY)
0.8485
+0.02
(+2.65%)
USD |
NASDAQ |
Dec 10, 12:36
Femasys Profit Margin (Quarterly): -575.1% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Quantum-Si, Inc. | -6.47K% |
| AIM ImmunoTech, Inc. | -12.63K% |
| Perspective Therapeutics, Inc. | -12.43K% |
| Protalix Biotherapeutics, Inc. | 13.19% |
| Armata Pharmaceuticals, Inc. | -2.30K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -606.1% |
| Return on Assets | -138.7% |
| Return on Invested Capital | -180.1% |
| Gross Profit Margin (Quarterly) | 30.78% |
| Operating Margin (Quarterly) | -500.9% |
| Return on Net Operating Assets | -257.3% |